EP3525777A1 - Xanthohumol for use in treating haemorrhoidal disease - Google Patents
Xanthohumol for use in treating haemorrhoidal diseaseInfo
- Publication number
- EP3525777A1 EP3525777A1 EP17804652.0A EP17804652A EP3525777A1 EP 3525777 A1 EP3525777 A1 EP 3525777A1 EP 17804652 A EP17804652 A EP 17804652A EP 3525777 A1 EP3525777 A1 EP 3525777A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- xanthohumol
- composition according
- composition
- weight
- haemorrhoidal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
Definitions
- Haemorrhoids are commonly called haemorrhoids only when they cause haemorrhoidal ailments. They however remain unnoticed until they are of normal size and are able to perform their precise rectal closure function (F. H. Wullink, Hemoroidy. Poradnik dla pacjentow, 1st Polish edition, ed. K. Matysiak, Wroclaw 2008, pages 10-11.)
- DC electrotherapy requires time-consuming (up to 14 minutes) DC applications. Time and intensity increase with the progression of piles. Repeated applications to the same place are recorded in 30% of patients.
- Infrared photocoagulation focuses the infrared radiation from the halogen lamp through the polymer probe at its top.
- the 0.5-2 second energy pulses are delivered to the base of the vascular bundle, which penetrate about 2.5 mm into the tissue.
- the most effective method is rubber bands, and patients undergoing this procedure are least often treated for haemorrhoids. Unfortunately, this group of patients simultaneously reported most often pain after surgery. In conclusion it might be admitted that non-surgical methods may be considered as the initial procedures of choice in patients with grade I and II haemorrhoids and early, small piles in grade III.
- composition of the invention is preferably in the form of a semi-solid such as an ointment or a cream, preferably comprising a petrolatum as a physiologically acceptable excipient.
- the composition comprises xanthohumol in an amount ranging from 0.001% by weight to 5.0% by weight of xanthohumol in terms of the total weight of the composition, more preferably, the composition comprises xanthohumol in an amount ranging from 0.01% by weight to 1.0% by weight of xanthohumol in terms of the total weight of the composition, most preferably, the composition comprises xanthohumol in an amount ranging from 0.1 % by weight to 0.5% by weight of xanthohumol in terms of the total weight of the composition.
- Xanthohumol also forms complexes with metals, especially with transition metals such as copper or zinc. Such xanthohumol complexes may also be used according to the invention.
- compositions may also contain one or more buffers, stabilizing agents, surfactants, wetting agents, lubricating agents, emulsifiers, suspending agents, preservatives, antioxidants, matting agents, lubricants, processing aids, dyes, sweeteners, perfumes, flavours and other known additives providing an elegant presentation of the drug or helping in the manufacture of a pharmaceutical or cosmetic or care product (i.e. a drug, a medicinal preparation, a medical product, a cosmetic product).
- a pharmaceutical or cosmetic or care product i.e. a drug, a medicinal preparation, a medical product, a cosmetic product.
- composition of the invention may be advantageously administered as an ointment or suppositories, however, other pharmaceutical or cosmetic forms such as a cream, gel or spray or dusting powder, powder or wet wipe may also be convenient for the patient or the recipient of the product.
- xanthohumol is effective and causes a gradual reversion of the symptoms of the haemorrhoidal disease to its complete disappearance even in the advanced grade of the haemorrhoidal disease.
- xanthohumol has a regenerating, nourishing, antipruritic and care effect on the skin around the anus, eliminating burning sensation and soreness, resulting in a noticeable improvement and alleviation, especially in the case of irritation of the anus and and the anal area.
- Embodiment 5 Use of xanthohumol in the anal area for the skin care purposes
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL419082A PL235226B1 (pl) | 2016-10-12 | 2016-10-12 | Ksantohumol do zastosowania w leczeniu lub zapobieganiu i profilaktyce chorób hemoroidalnych oraz kompozycja zawierająca ksantohumol |
PCT/IB2017/056302 WO2018069855A1 (en) | 2016-10-12 | 2017-10-12 | Xanthohumol for use in treating haemorrhoidal disease |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3525777A1 true EP3525777A1 (en) | 2019-08-21 |
Family
ID=59684565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17804652.0A Withdrawn EP3525777A1 (en) | 2016-10-12 | 2017-10-12 | Xanthohumol for use in treating haemorrhoidal disease |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3525777A1 (pl) |
PL (1) | PL235226B1 (pl) |
WO (1) | WO2018069855A1 (pl) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL429672A1 (pl) * | 2019-04-17 | 2020-10-19 | Bioxan Spółka Z Ograniczoną Odpowiedzialnością | Preparat zawierający ksantohumol i zastosowanie ksantohumolu |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103751717B (zh) * | 2014-01-13 | 2015-11-18 | 李绍华 | 一种治疗痔疮的药物组合物 |
CN103845615B (zh) * | 2014-03-24 | 2016-03-30 | 李周全 | 一种治疗阴道炎的药物组合物 |
-
2016
- 2016-10-12 PL PL419082A patent/PL235226B1/pl unknown
-
2017
- 2017-10-12 EP EP17804652.0A patent/EP3525777A1/en not_active Withdrawn
- 2017-10-12 WO PCT/IB2017/056302 patent/WO2018069855A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2018069855A1 (en) | 2018-04-19 |
PL235226B1 (pl) | 2020-06-15 |
PL419082A1 (pl) | 2017-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6778219B2 (ja) | 皮膚の炎症を抑制するイガイ接着タンパク質製品及びその適用 | |
US5504117A (en) | Pharmacologic preparation for the treatment of anal disorders | |
HU211823A9 (en) | Formulations containing hyaluronic acid | |
MXPA00009705A (es) | Uso de poliaminas en el tratamiento de sintomas dermatologicos. | |
HU211689A9 (en) | Treatment of disease employing hyaluronic acid and nsaids | |
JP6104390B2 (ja) | ミクロスフェアを含む改良された創傷治癒用組成物 | |
US20060240119A1 (en) | Pharmacologically active strong acid solutions | |
US20210236446A1 (en) | Wound healing composition | |
RU2433844C1 (ru) | Способ лечения дегенеративно-дистрофических заболеваний опорно-двигательного аппарата и посттравматических болевых синдромов | |
WO2018069855A1 (en) | Xanthohumol for use in treating haemorrhoidal disease | |
RU2318503C1 (ru) | Способ лечения анальной трещины | |
RU2366648C2 (ru) | Продукт взаимодействия двуокиси селена с алифатическими галоидкарбоновыми кислотами, способ получения продукта, раствор продукта и способ лечения доброкачественных, вирусных, предзлокачественных и злокачественных неметастазирующих поражений кожи, диспластических поражений видимых слизистых оболочек и иных поражений кожи | |
RU2538079C1 (ru) | Композиция для лечения анальных трещин | |
TW202339711A (zh) | 預防或治療心血管疾病的高穿透性的阿司匹靈和其他非類固醇抗發炎藥的前藥 | |
RU2702347C2 (ru) | Лечение или профилактика себорейного кератоза с применением артемизинина и его производных | |
CN100531727C (zh) | 含有维生素k1氧化物或其衍生物的组合物用于治疗和/或预防哺乳动物皮肤损害的用途 | |
RU2375054C2 (ru) | Препарат для лечения поражений кожи, способ получения препарата (варианты) и способ лечения поражений кожи | |
RU2445100C2 (ru) | Консервативный способ комплексного лечения острых и хронических анальных трещин | |
RU2595799C1 (ru) | Композиция для лечения анальных трещин в форме крема | |
US20190365735A1 (en) | Compositions and methods for treating varicose veins | |
CN108404094A (zh) | 一种疏络止痛消炎蜂毒应用调理膏 | |
Gallese | Treatment Protocol of the Most Common Anorectal Pathologies with Association between Micronized Purified Flavonoid Fraction and Sucralfate for Local Appli-cation | |
CN117100818A (zh) | 一种治疗痔疮的外用膏剂及其制备方法 | |
CN116077523A (zh) | 一种用于防治痔疮的组合物及其制备方法与应用 | |
WO2015048930A1 (zh) | 一种含氯诺昔康和聚维酮碘的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20190508 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20220503 |